60 related articles for article (PubMed ID: 23755906)
1. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy.
Kanadiya MK; Gohel TD; Sanaka MR; Thota PN; Shubrook JH
J Diabetes Complications; 2013; 27(5):463-6. PubMed ID: 23755906
[TBL] [Abstract][Full Text] [Related]
2. Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus.
Lam R; Hwang WT; Chennareddy S; Boursi B; Yang YX
Dig Dis Sci; 2024 May; 69(5):1834-1843. PubMed ID: 38517561
[TBL] [Abstract][Full Text] [Related]
3. Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.
Lawler T; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
Cancer Epidemiol; 2024 Jun; 90():102566. PubMed ID: 38518387
[TBL] [Abstract][Full Text] [Related]
4. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
[TBL] [Abstract][Full Text] [Related]
6. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.
Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM
Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092
[TBL] [Abstract][Full Text] [Related]
7. Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis.
Jung YS; Park CH; Eun CS; Park DI; Han DS
J Gastroenterol Hepatol; 2017 May; 32(5):957-965. PubMed ID: 28449338
[TBL] [Abstract][Full Text] [Related]
8. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis.
Hou YC; Hu Q; Huang J; Fang JY; Xiong H
Oncotarget; 2017 Jan; 8(5):8843-8853. PubMed ID: 27903961
[TBL] [Abstract][Full Text] [Related]
9. Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?
Canha MI; Ramos G; Prata R; Lages Martins P; Viúla Ramos M; Coimbra J
J Gastrointest Cancer; 2024 Mar; 55(1):435-443. PubMed ID: 37987968
[TBL] [Abstract][Full Text] [Related]
10. Bee Products and Colorectal Cancer-Active Components and Mechanism of Action.
Moskwa J; Naliwajko SK; Dobiecka D; Socha K
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049455
[TBL] [Abstract][Full Text] [Related]
11. Preparing for Colonoscopy in People with Diabetes: A Review with Suggestions for Clinical Practice.
Chirila A; Nguyen ME; Tinmouth J; Halperin IJ
J Can Assoc Gastroenterol; 2023 Feb; 6(1):26-36. PubMed ID: 36789141
[TBL] [Abstract][Full Text] [Related]
12. Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes.
Huang QY; Yao F; Zhou CR; Huang XY; Wang Q; Long H; Wu QM
World J Clin Cases; 2020 Dec; 8(24):6213-6228. PubMed ID: 33392303
[TBL] [Abstract][Full Text] [Related]
13. Review of Associations Between Type 2 Diabetes and Cancer.
Bonagiri PR; Shubrook JH
Clin Diabetes; 2020 Jul; 38(3):256-265. PubMed ID: 32699474
[TBL] [Abstract][Full Text] [Related]
14. Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects.
Kamarudin MNA; Sarker MMR; Zhou JR; Parhar I
J Exp Clin Cancer Res; 2019 Dec; 38(1):491. PubMed ID: 31831021
[TBL] [Abstract][Full Text] [Related]
15. Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes.
Demb J; Yaseyyedi A; Liu L; Bustamante R; Earles A; Ghosh P; Gutkind JS; Gawron AJ; Kaltenbach TR; Martinez ME; Gupta S
Clin Transl Gastroenterol; 2019 Nov; 10(11):e00092. PubMed ID: 31770138
[TBL] [Abstract][Full Text] [Related]
16. Different effects of metformin and insulin on primary and secondary chemoprevention of colorectal adenoma in diabetes type 2: Traditional and Bayesian meta-analysis.
Mansourian M; Karimi R; Vaseghi G
EXCLI J; 2018; 17():45-56. PubMed ID: 29383018
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Surveillance Adenoma and Sessile Serrated Polyp Detection Rates.
Maratt JK; Dickens J; Schoenfeld PS; Elta GH; Jackson K; Rizk D; Erickson C; Menees SB
Dig Dis Sci; 2017 Dec; 62(12):3579-3585. PubMed ID: 29043592
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
